New genomics study aims to evaluate effectiveness of blood test in detecting breast cancer
Can't see this email? View it online
   
  October 12, 2017  
  Breast Cancer  
  The latest breast cancer news from News Medical  
 New genomics study aims to evaluate effectiveness of blood test in detecting breast cancerNew genomics study aims to evaluate effectiveness of blood test in detecting breast cancer
 
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
 
 
 Exposure to environmental chemicals linked to development of breast cancerExposure to environmental chemicals linked to development of breast cancer
 
Exposure to environmental chemicals, especially early in life, is an important contributing factor in the development of breast cancer, according to the most comprehensive review of human studies to date.
 
   Survey highlights major gap in women’s knowledge about genomic testing in breast cancerSurvey highlights major gap in women’s knowledge about genomic testing in breast cancer
 
Breast cancer is the most feared type of cancer among women in Germany, according to a recent representative survey commissioned by Agendia, a world leader in personalized medicine and molecular cancer diagnostics.
 
   New U-M study examines why overtreatment in older breast cancer patients persistsNew U-M study examines why overtreatment in older breast cancer patients persists
 
Recent clinical trials have shown that 90 percent of early stage breast cancer patients over age 70 do not benefit from radiation after breast-conserving surgery. And yet, use of radiation in this context has dropped only minimally.
 
   Study reveals how different breast cancer treatments impact employment experiences of womenStudy reveals how different breast cancer treatments impact employment experiences of women
 
A new study reveals that patients with breast cancer who received more aggressive treatments were more likely to experience disruptions in employment. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may be helpful for patients who are comparing their options for breast cancer treatment.
 
 Yale scientists unravel molecular mechanism of breast cancer risk gene
 
Yale scientists unravel molecular mechanism of breast cancer risk geneMore than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women to breast cancer, Yale scientists have pinpointed the molecular mechanism that allows those mutations to wreak their havoc.
 
 
 New drug shows promise to treat women with estrogen positive metastatic breast cancer
 
New drug shows promise to treat women with estrogen positive metastatic breast cancerZ-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.
 
 
 Study uncovers differences in bacterial composition of healthy vs. cancerous breast tissue
 
Study uncovers differences in bacterial composition of healthy vs. cancerous breast tissueIn a newly published study, Cleveland Clinic researchers have uncovered differences in the bacterial composition of breast tissue of healthy women vs. women with breast cancer.
 
 
 Bariatric surgery linked to reduced risk of cancer for severely obese patients
 
Bariatric surgery linked to reduced risk of cancer for severely obese patientsSeverely obese patients who undergo bariatric surgery lower their risk of developing cancer by at least a third, according to a University of Cincinnati College of Medicine researcher leading a large retrospective cohort study of patients in the western United States.
 
 
 Clinical trial tests frankincense as potential breast, colon cancer treatment
 
Clinical trial tests frankincense as potential breast, colon cancer treatmentCancer surgeon and researcher Nancy DeMore is leading a clinical trial using frankincense to try to treat breast and colon cancer at the Medical University of South Carolina. The study was inspired by a research specialist in DeMore's lab.
 
 
 NTNU professors provide insight into pros and cons of early disease detection
 
NTNU professors provide insight into pros and cons of early disease detectionEver improving medical technology allows doctors to also discover conditions and precursors of disease that may never progress. To be on the safe side, most people still want to receive treatment.